Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COCONUT: Glucagon and GLP-1 Co-agonism in T2DM
NCT04307797Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jan 2022
- Primary completion
- Oct 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide, glucagon in type 2 diabetes mellitus (T2DM), obesity, sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Jan 2022; status: completed.
02
Drugs
exenatideglucagon
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT04307797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04307797.